Deals with effect of activated ras oncogenes in the absence of multidrug resistance on the sensitvity of human tumor cells to topoisomerase II inhibitors. Opinion on the compounds NSC 284682 and NSC 658687; Comparison of non-DNA-intercalating epipodophyllotoxins with DNA-intercalating inhibitors.